|
:
HIV Patients and Weight Loss: Optimizing Care to Improve
Outcomes is presented by Dr. Robert Demling, Professor of Surgery
at Harvard Medical School and Director of the Burn-Trauma Center at Brigham and
Women’s Hospital, Dr.
Christine Wanke, Professor of Medicine and Public Health and Director of the
Division of Nutrition and Infection at Tufts University School of Medicine and Dr. Donald Kotler, Professor
of Medicine at Columbia University
College of Physicians and Surgeons and Chief of the Division of
Gastroenterology and Liver Disease at St. Luke’s Roosevelt Hospital Center.
HIV-associated wasting was first identified by the Centers for Disease Control as an AIDS
defining condition in 1987. With the advent of highly active antiretroviral
therapy, it was hoped that control of viral count would result in the
elimination of wasting as a major sequel of HIV infection. This has turned out
not to be the case. HIV wasting remains a serious, debilitating, and sometimes
life-threatening condition. Care providers need to be vigilant to identify and
properly treat patients who suffer from this disorder.
This activity will review the pathogenesis of protein energy
malnutrition in general and its relation to the etiology of HIV-related weight
loss. Additionally, we will discuss the epidemiology of HIV-associated wasting
and the treatment options available.
ArcMesa Educators is
accredited by the Accreditation Council for Continuing Medical Education to
provide continuing medical education for physicians. ArcMesa Educators
designates this educational activity for a maximum of 1 AMA PRA Category
1 credits™. Physicians should only claim credit commensurate
with the extent of their participation in the activity.
| ArcMesa Educators is accredited
by the Accreditation Council for Pharmacy Education as a Provider of
continuing pharmacy education. (UPN 200-000-08-002-H02-P). Pharmacists will
receive 1 contact hour (0.1 CEU) for successful completion of this
activity. |
 |
ArcMesa Educators is an approved provider of continuing education in
nursing by ASNA, an accredited approver by the ANCC Commission on
Accreditation. (ANCC AL #5-85). ArcMesa is an approved provider by the
Florida Board of Nursing (#FBN2002). Nurses will receive 1 contact hour
(0.1 CEU) for successful completion of this activity.
By reviewing
the course content and successfully completing the post-test and evaluation, physicians
are entitled to receive 1 AMA PRA category 1 credit.™, nurses and
pharmacists will receive 1 contact hour. Statement of credit will be available to print from your user history page.
Upon completion of this activity, participants should be able to:
- List physiologic factors affecting energy intake
and metabolic abnormalities that may lead to weight loss in HIV positive
patients
- Discuss the need for pharmacologic and
nonpharmacologic approaches to improve weight in HIV positive patients
- Examine the impact of HIV related weight loss
on patient outcomes
- Develop management strategies to address
weight loss in HIV positive patients
This activity is intended
for physicians, pharmacists, and nursing professionals involved with the
care of patients with HIV.
Robert
Demling, MD
Nothing to
Disclose
Donald
Kotler, MD
Grants/Research
Support recipient, Speakers’ Bureau, Consultant – EMD Serono
Laboratories
Christine
Wanke, MD
Nothing to
Disclose
The employees of ArcMesa Educators have no financial relationships to disclose.
It is the policy of ArcMesa Educators to ensure balance, independence, objectivity, and scientific rigor in all its educational activities. All faculty/authors are expected to disclose any relevant financial relationships they may have with commercial interests in relation to this activity. These relationships, along with the educational content of this program, have been reviewed and any potential conflicts of interest have been resolved to the satisfaction of ArcMesa Educators.
©2008 ArcMesa Educators, LLC. All rights reserved. None of the contents may be reproduced in any form without prior written permission from ArcMesa Educators.
The recommendations made in this program are based upon a combination of randomized clinical trials, current guidelines, and the clinical practice experience of the participating panelists. Any medications, diagnostic procedures or treatments discussed by the panelists should not be utilized without evaluation of their patient's conditions. Participants are urged to consult the full prescribing information on any drug mentioned in this activity for recommended dosage, indications, contraindications, warnings, precautions, and adverse effects before prescribing any medication.
Printer settings may vary. Please use landscape layout option.
|
|
|
Robert Demling,
MD - Chair
|
Professor of Surgery, Harvard Medical School
Director of the Burn-Trauma Center, Brigham and Women’s
Hospital, Boston, MA |
Donald Kotler,
MD |
Professor of Medicine, Columbia University College of
Physicians and Surgeons
Chief, Division of Gastroenterology and Liver Disease, St.
Luke’s Roosevelt Hospital Center, NY, New York |
Christine Wanke,
MD |
Professor of Medicine and Public Health
Director, Division of Nutrition and
Infection Associate Chair, Department of Public Health Tufts University
School of Medicine, Boston, MA |
|
|
Faculty: 
